Ovarian Cancer Treatment: Carboplatin and Mirvetuximab Soravtansine

We are studying a combination of carboplatin and a new drug, Mirvetuximab soravtansine, for patients with recurrent ovarian cancer that is sensitive to platinum-based chemotherapy. This trial aims to see if this treatment improves response rates in patients with specific tumor characteristics.

>2 years 11-15 visits Efficacy phase (II)Post-Trial Drug Access No Placebo Investigational Medicines InjectionOncology

What diseases are being studied?

Health conditions and diseases that the clinical trial is designed to study and treat.

Who can participate in the clinical trial?

These questions help us understand your situation so we can let the trial team know whether you might be a potential match. This is not a medical evaluation and is not part of the official screening, the study doctor will make the final decision..

What medicines are being studied?

Medicines that are officially approved for use in the European Union and considered safe by EMA. These medicines are already on the market and may be tested for new conditions or populations.

Carboplatin Accord

Carboplatin Accord is a chemotherapy medicine used to treat several types of cancer.

Pred Forte

Pred Forte is an eye drop used to reduce inflammation and swelling after eye injury, surgery, or with certain eye conditions.

What active substances are being studied?

Active substances that are officially approved for use in the European Union and considered safe by EMA. These substances are already on the market and may be tested for new conditions or populations.

Carboplatin

Carboplatin is a chemotherapy substance used to treat various cancers by damaging cancer cells and slowing tumor growth.

Mirvetuximab Soravtansine

Mirvetuximab soravtansine is a targeted antibody-linked therapy that delivers a cell-killing agent to ovarian cancer cells expressing folate receptor alpha.

Prednisolone Acetate

Prednisolone acetate is a steroid that reduces inflammation and allergic reactions, commonly used for eye and skin conditions.

What experimental substances are being tested?

Experimental substances that are being investigated in this clinical trial. These are not yet approved for general use.

Ribocarbo

What similar medicines might you know?

Don't worry if you don't know the medicines tested in the trial. There is a chance you have heard about the similar medicines. Check the list below to see if you are familiar with any of them.

Carbo-Cell

Carbomedac

Carboplan

Where is the clinical trial being conducted?

Locations and medical facilities where this clinical trial is currently recruiting or conducting research. Select the locations where you would like to participate.

Loading map...

UZ Leuven

Gynaecologic oncology

Heverlee, Belgium

Hopital De Libramont

Oncology

Neufchâteau, Belgium

Cliniques Universitaires Saint-Luc

Medical Oncology

Sint-Stevens-Woluwe, Belgium

Sponsor: AbbVie Deutschland GmbH & Co. KG

Last updated: Nov 26, 2025

Disclaimer: Parts of this content have been automatically extracted from the EU Clinical Trials registry. While we strive for accuracy, please always contact the trial site or sponsor directly for correct and official information before making any decisions about participation. View on EU Clinical Trials.